Hfm Investment Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Hfm Investment Advisors, LLC
- $206 Billion
- Q1 2025
A detailed history of Hfm Investment Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Hfm Investment Advisors, LLC holds 1 shares of AGIO stock, worth $28. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$28% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
236Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$161 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$137 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$99.3 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$69.2 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.55B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...